NCT01821794: Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B |
|
|
| Active, not recruiting | 3 | 26 | US | Peginterferon and Tenofovir | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Chronic Hepatitis B e Antigen Negative, Chronic Hepatitis B e Antigen Positive | 03/13 | 12/17 | | |
NCT02131025: A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen |
|
|
| Active, not recruiting | 3 | 428 | US, Canada | ABC/DTG/3TC FDC, Ongoing cART regimen | ViiV Healthcare, PPD, GlaxoSmithKline | Infection, Human Immunodeficiency Virus | 04/15 | 10/15 | | |
NCT02349984: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer |
|
|
| Recruiting | 2/3 | 105 | RoW | Recombinant anti-tumor and anti-virus protein for injection, Novaferon, Saline Injection, Brand name: Novaferon | Beijing Genova Biotech Company, Ltd. | Metastatic Colorectal Cancer | 05/15 | 05/15 | | |
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia |
|
|
| Active, not recruiting | 2/3 | 640 | US, Canada, RoW | Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis | Children's Oncology Group, National Cancer Institute (NCI) | Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma | 12/20 | 12/20 | | |
